Back
Nuveen Municipal Credit Income Fund Vs. Blueprint Medicines Industry Stock Comparison
Sell
30
NZF
Nuveen Municipal Credit Income Fund
Last Price:
$12.26
Seasonality Move:
-1.1%
Sell
45
BPMC
Blueprint Medicines
Last Price:
$110.07
Seasonality Move:
4.12%
Sell
30
Nuveen Municipal Credit Income Fund (NZF)
is a Sell
Is Nuveen Municipal Credit Income Fund a Buy, Sell or Hold?
-
The current Nuveen Municipal Credit Income Fund [NZF] share price is $12.26. The Score for NZF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NZF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $110.05. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NZF Stock Price Chart
What is Nuveen Municipal Credit Income Fund's stock price today?
-
The Nuveen Municipal Credit Income Fund share price today is $12.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NZF is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $110.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NZF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 43.34 | Sell |
Chaikin Money Flow: | 28873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.11 - 12.57) | Sell |
Bollinger Bands (100): | (12.42 - 12.98) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.15 | Buy |
Relative Strength Index (14 RSI): | 69.84 | Buy |
Chaikin Money Flow: | 891346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (87.35 - 99.95) | Buy |
Bollinger Bands (100): | (86.7 - 97) | Buy |
NZF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.23 | Buy |
20-day SMA: | 12.25 | Buy |
50-day SMA: | 12.55 | Sell |
200-day SMA: | 12.46 | Sell |
8-day EMA: | 12.24 | Buy |
20-day EMA: | 12.32 | Sell |
50-day EMA: | 12.48 | Sell |
200-day EMA: | 12.43 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.66 | Buy |
20-day SMA: | 93.45 | Buy |
50-day SMA: | 94.81 | Buy |
200-day SMA: | 97.03 | Buy |
8-day EMA: | 101.17 | Buy |
20-day EMA: | 96.44 | Buy |
50-day EMA: | 94.26 | Buy |
200-day EMA: | 92.14 | Buy |
Nuveen Municipal Credit Income Fund Earnings Growth & NZF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $2.89 per share.
Nuveen Municipal Credit Income Fund Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |